β2 Integrin-mediated Cell-Cell Contact Transfers Active Myeloperoxidase from Neutrophils to Endothelial Cells*
暂无分享,去创建一个
F. Luft | W. Nauseef | R. Kettritz | S. Rolle | B. Purfürst | U. Jerke | Uwe Jerke
[1] A. Kettle,et al. Myeloperoxidase: a front‐line defender against phagocytosed microorganisms , 2013, Journal of leukocyte biology.
[2] A. Kettle,et al. Ceruloplasmin Is an Endogenous Inhibitor of Myeloperoxidase* , 2013, The Journal of Biological Chemistry.
[3] J. Flemmig,et al. The Fluorescein-derived Dye Aminophenyl Fluorescein Is a Suitable Tool to Detect Hypobromous Acid (HOBr)-producing Activity in Eosinophils* , 2012, The Journal of Biological Chemistry.
[4] C. Meisinger,et al. Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study , 2012, Journal of internal medicine.
[5] M. Rane,et al. Granule Exocytosis Contributes to Priming and Activation of the Human Neutrophil Respiratory Burst , 2011, The Journal of Immunology.
[6] M. Sperandio,et al. Myeloperoxidase attracts neutrophils by physical forces. , 2011, Blood.
[7] A. Kettle,et al. Urate as a Physiological Substrate for Myeloperoxidase , 2011, The Journal of Biological Chemistry.
[8] C. Lam,et al. Prognostic value of plasma myeloperoxidase in ESRD patients. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] S. Hazen,et al. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation , 2010, Nature Medicine.
[10] M. Gollasch,et al. BK channels in innate immune functions of neutrophils and macrophages. , 2009, Blood.
[11] W. Nauseef. How human neutrophils kill and degrade microbes: an integrated view , 2007, Immunological reviews.
[12] M. Glennie,et al. Intimate Cell Conjugate Formation and Exchange of Membrane Lipids Precede Apoptosis Induction in Target Cells during Antibody-Dependent, Granulocyte-Mediated Cytotoxicity1 , 2007, The Journal of Immunology.
[13] A. Schmaier,et al. Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system. , 2007, The American journal of pathology.
[14] M. Wellner,et al. NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils. , 2007, Blood.
[15] S. Hazen,et al. Serum myeloperoxidase and mortality in maintenance hemodialysis patients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] R. Leboeuf,et al. Expression of Human Myeloperoxidase by Macrophages Promotes Atherosclerosis in Mice , 2005, Circulation.
[17] Denise Lau,et al. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[18] C. Remacle,et al. Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation. , 2004, Biochemical and biophysical research communications.
[19] A. Chait,et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[20] E. Topol,et al. Prognostic value of myeloperoxidase in patients with chest pain. , 2003, The New England journal of medicine.
[21] A. Exley,et al. Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.
[22] F. Crea,et al. Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.
[23] P. Heeringa,et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. , 2002, The Journal of clinical investigation.
[24] Chunxiang Zhang,et al. Myeloperoxidase, a Leukocyte-Derived Vascular NO Oxidase , 2002, Science.
[25] T. Mayadas,et al. Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation. , 2001, Blood.
[26] D. Boyle,et al. Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. , 1997, Journal of immunology.
[27] B. Persson,et al. Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin? , 1997, Clinical and experimental immunology.
[28] L. Kjeldsen,et al. Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. , 1995, Journal of immunology.
[29] L. Kjeldsen,et al. Control of exocytosis in early neutrophil activation. , 1993, Journal of immunology.
[30] J. Loike,et al. The Role of Protected Extracellular Compartments in Interactions between Leukocytes, and Platelets, and Fibrin/Fibrinogen Matrices a , 1992, Annals of the New York Academy of Sciences.
[31] S. Weiss,et al. Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. , 1990, Science.
[32] H. Baum,et al. Inactivation of alpha‐1‐proteinase inhibitor in serum by stimulated human polymorphonuclear leucocytes. Evidence for a myeloperoxidase‐dependent mechanism , 1988, Cell biochemistry and function.
[33] R. Senior,et al. Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. , 1982, The Journal of clinical investigation.
[34] Y. Zotterman,et al. Baroceptive Impulses in the Carotid Sinus and Their Relation to the Pressure Reflex , 1941 .